tiprankstipranks
Humacyte (HUMA)
:HUMA
US Market

Humacyte (HUMA) Income Statement

Compare
1,107 Followers

Humacyte Income Statement

Last quarter (Q3 2024), Humacyte's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Humacyte's net income was $-39.20M. See Humacyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 1.56M$ 1.26M$ 1.49M$ 6.19M
Gross Profit
$ -76.55M$ -6.69M$ 1.21M$ -6.94M$ -69.42M
Operating Expenses
$ 23.50M$ 84.58M$ 81.21M$ 64.60M$ 16.27M
Depreciation and Amortization
$ 7.72M$ 8.26M$ 8.28M$ 8.43M$ 6.75M
EBITDA
$ -96.46M$ 2.49M$ -72.97M$ -56.25M$ -78.94M
Operating Income
$ -100.05M$ -84.58M$ -81.21M$ -64.60M$ -85.69M
Other Income/Expenses
$ -10.73M$ 72.61M$ 54.73M$ -1.92M$ 269.00K
Pretax Income
$ -110.78M$ -11.96M$ -26.48M$ -66.52M$ -85.42M
Net Income
$ -110.78M$ 64.22M$ 37.54M$ -68.73M$ -85.42M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.07$ 0.62$ 0.94$ -5.52$ -4.25
Diluted EPS
$ -1.07$ 0.62$ 0.94$ -5.52$ -4.25
Weighted Average Shares Outstanding
103.42M 103.05M 39.97M 12.45M 20.12M
Weighted Average Shares Outstanding (Diluted)
103.42M 103.05M 39.97M 12.45M 20.12M
Currency in USD

Humacyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis